drugset / Trial / NCT03228238

ANti-Oxidant in Variant Angina (ANOVA) Trial

NCT03228238 ↗

Phase 4 Terminated 320 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Purpose Objectives 1. To evaluate the anti-oxidant effect of long-term Vitamin C+E therapy on coronary vasospasm improvement. 2. To evaluate the anti-oxidant effect of long-term statin therapy on coronary vasospasm improvement. 3. To evaluate the effect of long-term Vitamin C+E and statin therapy on regression of atheroma in target coronary vessels via intravascular ultrasound. 4. To find out the role of vascular endothelium in variant angina via evaluating long-term Vitamin C+E and statin therapy on improvement in vascular endothelial function by assessing brachial arterial expansion capability. 5. To find out the role of vascular endothelium in variant angina via evaluating long-term Vitamin C+E and statin therapy on improvement in arterial stiffness by assessing pulse wave velocity(PWV)

Timeline

Start
2014-09-01
Primary completion
2024-06-01
Completion
2024-06-01

Outcome

Outcome not reported

Stopped (Enrollment): “The study was terminated early due to slow recruitment and the Principal Investigator's retirement.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —
Subject Tocopherol Unknown 400 iu —
Subject Vitamin C Other / unclassified 1 g —

Indications